CasNo.51352-87-5,High quality Methyl 3-(2-(benzyl(Methyl)aMino)ethyl)benzoate hydrochloride with low price bulk in supply,(51352-87-5) Suppliers

1 Kilogram	FOB Price:USD 100.0000 -102.0000

Min.Order :1 Kilogram
Purity: 99%
Payment Terms : T/T,Other

Keywords

Methyl 3-(2-(benzyl(Methyl)aMino)ethyl)benzoate hydrochloride High quality Methyl 3-(2-(benzyl(Methyl)aMino)ethyl)benzoate hydrochloride 51352-87-5

Quick Details

Appearance:white Powder
Application:dietary supplement and Brain fitness products additives CAS 51352-87-5
PackAge:25kg/carton drum(32cm*58cm)or 1kg/foil bag(10cm*15cm) or by request of clients
ProductionCapacity:5000|Kilogram|Month
Storage:keep it away from heat and sunshine
Transportation:EMS,DHL,UPS,and by air or by sea

Superiority:

KONO is a leading manufacturer and supplier of chemicals in China. We develop ,produce and distribute high quality pharmaceuticals, intermediates, special chemicals and other fine chemicals.

We could give you:
1.Best quality in your requirement
2.Competitive price in China market
3.Mature Technical support
4.Professional logistic support
All we want is win-win business. Send yr. inquiries, you will get it!

Details:

CAS 51352-87-5 Nootropics 99% PRL-8-53

− − − − − − − − − − − − − − − − − − − − − − − − −

PRL-8-53

Cas No: 51352-87-5

Formula: C18H21NO2

Molecular Weight: 283.36 g/mol

Synonyms PRL-8053;PRL-8-53;Methyl 3-(2-(benzyl(Methyl)aMino)ethyl)benzoate hydrochloride

Asssy 99%+

Appearance: White crystalline powder

Application:Diatery supplements ,Nootropics,cholinergics

PRL-8-53 is a popular synthetic nootropic agent. It is a novel monoamine that is identified as 3-(2-benzylmethylamino ethyl) benzoic acid methyl ester hydrochloride. It is a derivative of benzoic acid comprised of the phenethylamine skeleton. Its unique structural properties meet the criteria required for cholinergic receptors interaction. Experimental animal studies have shown that PRL-8-53 produces cholinergic responses.

PRL-8-53 is considered as a nootropic agent that remains to be a research compound to date. It was developed and patented by Dr. Nikolaus Hansl during the 1970s while he was working at Creighton University. The acronym PRL came from its previous patent holder Pacific Research Labs. Please note that there is very little published clinical research done to evaluate the effects and safety of this chemical agent. These published studies are even undertaken by the creator himself which might present bias towards its efficiency. For this reason, it is advised that one exercise precautions with this research nootropic compound. Despite the lack of supporting literature however, anecdotal reports appear very favorable.

CAS 51352-87-5 Nootropics 99% PRL-8-53

A. Improved retention and acquisition

B. Decrease memory difficulties in the elderlies

C. Improve visual reaction time

D. Promote CNS balance

English Name	Cas No.	Specification
Noopept	157115-85-0	98%
Pramiracetam	68497-62-1	98%
Piracetam	7491-74-9	98%
Oxiracetam	62613-82-5	98%
Coluracetam	135463-81-9	98%
Aniracetam	72432-10-1	98%
Fasoracetam	110958-19-5	98%
L-Theanine	3081-61-6	10%-98%
Alpha-GPC	28319-77-9	50%,98%
CDP-Choline	146929-33-1	98%
Sulbutiamine	3286-46-2	98%
Resveratrol	501-36-0	50%,98%
5-HTP	56-69-9	90%-98%
Prl-8-53	51352-87-5	99%
Sunifiram	314728-85-3	99%
IDRA-21	22503-72-6	99%
Unifiram	272786-64-8	99%
NSI-189	1270138-40-3	99%